Jan 18 (Reuters) - Melinta Therapeutics, Inc.:
* MELINTA THERAPEUTICS - ‚ÄçPARTNER COMMENCED NEW PROGRAM FOR A TOPICAL FORMULATION OF RADEZOLID, IN PREPARATION FOR SUBMITTING AN IND APPLICATION TO FDA Source text for Eikon: Further company coverage:
 